Amyloid-β Neurotoxicity Is Mediated by FISH Adapter Protein and ADAM12 Metalloprotease Activity

Based on a variety of genetic, biochemical, and neuropathological evidence, amyloid-β peptide (Aβ) has been suggested to be causal in Alzheimer's disease (AD). Aβ has been shown to mediate neurodegenerative and inflammatory changes associated with amyloid plaques, as well as exert direct neurot...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS Vol. 102; no. 8; pp. 3058 - 3063
Main Authors: Malinin, Nikolay L., Wright, Sarah, Seubert, Peter, Schenk, Dale, Griswold-Prenner, Irene, Iversen, L. L.
Format: Journal Article
Language:English
Published: United States National Academy of Sciences 22-02-2005
National Acad Sciences
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Based on a variety of genetic, biochemical, and neuropathological evidence, amyloid-β peptide (Aβ) has been suggested to be causal in Alzheimer's disease (AD). Aβ has been shown to mediate neurodegenerative and inflammatory changes associated with amyloid plaques, as well as exert direct neurotoxicity through oligomeric forms of Aβ. The mechanism of Aβ toxicity, however, remains largely unknown. In this work, we show that an early event after exposure of postmitotic neurons to Aβ is tyrosine phosphorylation of FISH adapter protein. FISH binds to and potentially regulates certain ADAM family members. We present evidence that FISH and ADAM12 mediate the neurotoxic effect of Aβ. Expression of an ADAM12 protease-deficient mutant (ADAM12ΔMP) blocks Aβ-induced neuronal death, and expression of an N-terminal fragment of FISH reduces Aβ toxicity. The C-terminal fragment of FISH containing the ADAMs binding region is found to be sufficient for induction of neuronal death, which is prevented by coexpression of the ADAM12ΔMP. Aβ treatment, as well as expression of the C-terminal toxic FISH fragment, induces accumulation of ADAM12 N-terminal cleavage product in conditioned medium, demonstrating activation of the ADAM metalloprotease/sheddase activity. ADAM12 protein is reduced in AD brains, pointing to a possible increase in ADAM12 proteolytic activity. These data suggest that Aβ toxicity is mediated by FISH and ADAM12 and may provide insights into therapeutic strategies for AD treatment.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
This paper was submitted directly (Track II) to the PNAS office.
To whom correspondence should be addressed. E-mail: irene.griswoldprenner@elan.com.
N.L.M., S.W., P.S., D.S., and I.G.-P. are equity holders of Elan Pharmaceuticals.
Edited by L. L. Iversen, University of Oxford, Oxford, United Kingdom
Abbreviations: Aβ, amyloid-β peptide; AD, Alzheimer's disease; EGFR, EGF receptor; HCC, human cortical culture; MMEM, modified minimal essential medium with Eagle's salts; WCL, whole-cell lysate; FISH, five SH3 domains; ADAM, a disintegrin and metalloprotease; ADAM12ΔMP, ADAM12 deleted metalloprotease domain.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.0408237102